Avantor, Inc.
Financials
Valuation Metrics
Avantor, Inc.'s Market Cap is $9.33B. At end of 2025 it was $7.77B. Ranked #986 of 3,112 in US market (top 32%), #669 of 1,667 on NYSE (top 40%), #66 of 206 in Health Care Equipment & Services (top 32%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $9.33B | US#986/3,112 Sec#66/206 |
| Revenue | $6.56B | US#759/3,112 Sec#40/206 |
| Net Income | $-578M | US—/3,112 Sec—/206 |
| Total Assets | $11.60B | US#906/3,112 Sec#43/206 |
| Net Assets | $5.63B | US#643/3,112 Sec#38/206 |
| Employees | 13,500 | US#500/3,112 Sec#48/206 |
| Value | ||
| P/B | 1.66x | US#959/3,112 Sec#50/206 |
| P/S | 1.42x | US#932/3,112 Sec#65/206 |
| EV/EBITDA | 459.90x | US#2,495/3,112 Sec#140/206 |
| FCF Yield | 3.09% | US#1,746/3,112 Sec#105/206 |
| Profitability | ||
| ROE | -10.27% | US#2,415/3,112 Sec#137/206 |
| ROA | -4.98% | US#2,516/3,112 Sec#140/206 |
| Op. Margin | -4.35% | US#2,551/3,112 Sec#149/206 |
| Revenue Growth | 0.53% | US#2,186/3,112 Sec#168/206 |
| Earnings Growth | -41.11% | US#1,807/3,112 Sec#91/206 |
| Financial Health | ||
| Debt Ratio | 105.96% | US#1,145/3,112 Sec#112/206 |
| Total Debt | $37M | US#2,603/3,112 Sec#157/206 |
| FCF | $288M | US#1,157/3,112 Sec#66/206 |
| Cash | $307M | US#1,408/3,112 Sec#78/206 |
| Current Ratio | 1.78x | US#1,403/3,112 Sec#124/206 |
| Net Debt/EBITDA | -13.70x | US#26/3,112 Sec#1/206 |
| Performance | ||
| 1Y Return | 20.29% | US#1,438/3,112 Sec#98/206 |
| 1M Return | 32.41% | US#33/3,112 Sec#7/206 |
| From 52W High | -14.22% | US#1,361/3,112 Sec#96/206 |
| 1Y MDD | -52.50% | US#2,501/3,112 Sec#152/206 |
| Trading | ||
| Volume | 7,863,834 shares | US#227/3,112 Sec#7/206 |
| Trading Value | $108M | US#857/3,112 Sec#67/206 |
| Per Share | ||
| EPS | $-0.78 | US—/3,112 Sec—/206 |
| BPS | $8.21 | US#1,912/3,112 Sec#114/206 |
Company Info
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.